{"id":6491,"name":"Breakout Ventures","slug":"breakout-ventures","website":"https://breakout.vc/","hqGeo":null,"stageFocus":[],"sectorTags":["AI / ML","Developer Tools"],"excludedSectors":[],"checkSizeMin":null,"checkSizeMax":null,"thesisSummary":null,"thesisNarrative":null,"logoUrl":null,"aumUsd":null,"submissionUrl":null,"linkedinUrl":null,"twitterHandle":null,"portfolio":[{"companyName":"CONSTELLATION","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Building foundation models to understand brains, bodies, and environments","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"REACH INDUSTRIES","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Establishing the visual intelligence layer for regulated environments","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"PHANTOM NEURO","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Bringing natural control to robotic systems with AI","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"STEALTH CO","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Automating chemical analysis to accelerate drug discovery and development","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"EPANA BIO","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Advancing autoimmune care with precision therapies","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"COPERNIC CATALYSTS","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Designing chemical catalysts using physics-based computation","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"NOETIK","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Training foundation models for human biology","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"ENPLUSONE BIO","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Harnessing enzymes to produce RNA-based therapeutics","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"CYTOVALE","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Combining hardware and AI to diagnose sepsis in real time","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"IMMUSOFT","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Engineering B cells to produce therapeutics within the body","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"VITRA LABS","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Reimagining the future of fertility with hormone-free IVF","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"ZYMOCHEM","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Increasing performance chemical yields with biomanufacturing","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"A-ALPHA BIO","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Discovering drugs through millions of protein-protein interactions","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"PASSKEY THERAPEUTICS","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Uncovering multifunctional drugs with advanced computation","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"GENERAL SENSE","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Decoding chemical signatures into sensory reasoning models","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"SURF BIO","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Stabilizing biologics to address drug delivery’s core challenge","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"TWELVE","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Transforming carbon dioxide emissions into useful chemicals","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"PARALLEL BIO","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Putting the immune system in a dish to improve drug discovery","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"CHECKERSPOT","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Producing hard-to-source fats and oils with microalgae","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"INCENDIA THERAPEUTICS","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Reprogramming the tumor microenvironment to eliminate cancer","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"SHIRATRONICS","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Defeating migraines using minimally invasive neuromodulation","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"CELLCHORUS","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Investigating single-cell interactions to improve cell therapies","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"TFC THERAPEUTICS","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Finding new therapeutic routes to stop cancer for good","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"ECOVATIVE DESIGN","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Driving plant-based meats and textiles with mycelium","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"MODERN MEADOW","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Innovating materials with bio-design technology","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"STRM.BIO","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Harnessing extracellular vesicles to deliver gene therapies in-vivo","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"CORTEXYME","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"Novel therapeutic approach to treating underlying causes of neurodegenerative diseases","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"EnPlusOne Biosciences","companyUrl":null,"stage":null,"sector":"RNA therapeutics / platform biotech","investmentYear":null,"description":"Uses enzymes to manufacture RNA‑based therapeutics more efficiently and at scale.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Surf Bio (exited)","companyUrl":null,"stage":null,"sector":"Biotech / drug delivery","investmentYear":null,"description":"Develops technologies to stabilize biologic drugs and improve drug delivery; acquired by Halozyme.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Cortexyme (exited)","companyUrl":null,"stage":"IPO (2019 exit).","sector":"Neurology biotech","investmentYear":null,"description":"Develops therapeutics targeting underlying causes of neurodegenerative diseases; went public in 2019.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Stealth Co – chemical analysis","companyUrl":null,"stage":null,"sector":"AI / cheminformatics","investmentYear":null,"description":"Stealth‑mode company automating chemical analysis to accelerate drug discovery and development.","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Stealth Co – reproducibility infra","companyUrl":null,"stage":null,"sector":"AI / R&D infrastructure","investmentYear":null,"description":"Stealth‑mode company building AI‑enabled reproducibility infrastructure for scientific innovations and commercial distribution.","amountUsd":null,"relevanceNote":null,"fundName":null}],"partnerCount":6,"partners":[{"id":29481,"name":"Dana Watt","title":"Partner","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/dana-watt-phd-01232195","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":29482,"name":"Susanna Harris","title":"Director of Community","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/susannalharris","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":29483,"name":"Julia Moore","title":"Managing Partner","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/juliatmoore","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":29484,"name":"Renée Shenton","title":"Chief of Staff","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/reneeshenton","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":29485,"name":"Lindy Fishburne","title":"Managing Partner","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/lindy-morris-fishburne-076157","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":29486,"name":"Nima Ronaghi","title":"Principal","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/nima-ronaghi","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]}],"funds":[],"activity":{"lastInvestmentYear":null,"investmentsLast12Months":0},"investorType":"vc","preferredApproach":null,"prefersFounderType":null,"oneClickPitchEnabled":false,"relatedFirms":[{"id":7722,"name":"Sheesha Finance","slug":"sheesha-finance","logoUrl":null,"website":"https://sheeshafinance.gitbook.io/","stageFocus":[],"sectorTags":["AI / ML","Developer Tools","Fintech"],"hqGeo":null},{"id":10061,"name":"dWeb Ventures","slug":"dweb-ventures","logoUrl":null,"website":"https://webventures.io/","stageFocus":["Seed"],"sectorTags":["Other","Developer Tools"],"hqGeo":"San Francisco, CA"},{"id":497,"name":"SBI Investment (SBI Group)","slug":"sbi-investment-sbi-group","logoUrl":null,"website":"https://www.sbinvestment.co.jp/","stageFocus":["Seed","Series A"],"sectorTags":["Fintech","Other","Developer Tools"],"hqGeo":"Tokyo, Japan"},{"id":11229,"name":"Meshare Ventures","slug":"meshare-ventures","logoUrl":null,"website":"https://v1.meshare.com/","stageFocus":["Pre-Seed"],"sectorTags":["Other","AI / ML","Fintech"],"hqGeo":"Nairobi, Kenya"},{"id":6827,"name":"Force Over Mass","slug":"force-over-mass","logoUrl":null,"website":"https://www.fomcap.com/","stageFocus":[],"sectorTags":["AI / ML","Developer Tools","Other","Fintech","SaaS","Healthcare","EdTech"],"hqGeo":null},{"id":5644,"name":"Project Canary Ventures","slug":"project-canary-ventures","logoUrl":null,"website":"https://www.projectcanary.com/","stageFocus":["Pre-Seed","Seed"],"sectorTags":["Other","AI / ML"],"hqGeo":"Denver, CO"}],"featuredIn":[{"slug":"ai","displayName":"AI & ML Investors","pageType":"industry"}],"fundraisingResources":[{"slug":"how-vcs-help-portfolio-raise-follow-on","title":"How VCs Can Actually Help Their Portfolio Companies Raise Follow-On"},{"slug":"how-many-investors-should-you-pitch","title":"How Many Investors Should You Pitch? The Math Most Founders Get Wrong"},{"slug":"what-vcs-actually-look-for-pitch-deck","title":"What VCs Actually Look for in a Pitch Deck"}],"overviewNarrative":null,"portfolioNarrative":null,"seoTitle":null,"seoDescription":null,"lastVerifiedAt":"2026-07-12T15:42:06.196Z"}